We are live on
!
Find out more
TAS
TIFF Advisory Services Portfolio holdings
AUM
$408M
1-Year Est. Return
20.34%
This Fund
S&P 500
This Quarter
Est. Return
+4.03%
1 Year Est. Return
+20.34%
3 Year Est. Return
+85.9%
5 Year Est. Return
+77.82%
10 Year Est. Return
+319.3%
AUM
$215M
AUM Growth
+$41.2M
(+24%)
Cap. Flow
+$34.6M
Cap. Flow
% of AUM
16.1%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
1
Reduced
3
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$68.3M |
| 2 |
CytomX Therapeutics
CTMX
|
+$289K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$23.1M |
| 2 |
RDFN
Redfin
RDFN
|
+$5.01M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.95M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.11M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.15% |
| 2 | Consumer Discretionary | 0% |
| 3 | Energy | 0% |
| 4 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard S&P 500 ETF
VOO
$956B
| $140M | 64.91% |
559,752
+275,118
| +97% | +$68.3M |
|
|
2
State Street Energy Select Sector SPDR ETF
XLE
$39B
| $43.5M | 20.22% |
1,146,000
-29,920
| -3% | -$1.11M |
|
|
3
State Street Financial Select Sector SPDR ETF
XLF
$56.5B
| $17.2M | 8% |
647,000
-39,740
| -6% | -$1.1M |
|
|
4
Vanguard FTSE Developed Markets ETF
VEA
$223B
| $14.5M | 6.72% |
336,843
-518,397
| -61% | -$23.1M |
|
|
5
CytomX Therapeutics
CTMX
$690M
| $320K | 0.15% |
+11,313
| New | +$289K |
|
|
6
iShares Russell 2000 ETF
IWM
$79.1B
| – | – |
-12,823
| Closed | -$1.95M |
|
|
RDFN
7
DELISTED
Redfin
RDFN
| – | – |
-208,796
| Closed | -$5.01M |
|
8
Star Group
SGU
$413M
| – | – |
-101,979
| Closed | -$1.01M |
|
|
APRN
9
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| – | – |
-441
| Closed | -$282K |
|
|
DRNA
10
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-29,714
| Closed | -$373K |
|
Similar funds
LECM
CIM
RCP
DW
HWM
QCI
WA
LPC
TIFF Advisory Services's Q2 2018 Portfolio in Review
As of Q2 2018, TIFF Advisory Services held 10 positions worth $215M, up 24% from $174M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TIFF Advisory Services deployed $34.6M of net new capital in Q2 2018, opening 1 new position and adding to 1 existing holding. Its largest new stake was CytomX Therapeutics: 11,313 shares worth $320K.
By sector, the portfolio is most concentrated in Healthcare at 0.15% of assets, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $23.1M trimmed.
- TIFF Advisory Services's largest Q2 2018 buy was CytomX Therapeutics: 11,313 shares worth $320K.
- TIFF Advisory Services added most to Vanguard S&P 500 ETF in Q2 2018, an estimated $68.3M increase.
- TIFF Advisory Services's biggest Q2 2018 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $23.1M.
- TIFF Advisory Services fully exited Redfin in Q2 2018, selling an estimated $5.01M.
- TIFF Advisory Services's ten largest holdings make up 100% of its $215M portfolio in Q2 2018.
- TIFF Advisory Services opened 1 new position and closed 5 in Q2 2018.
- TIFF Advisory Services's portfolio value rose 24% quarter-over-quarter to $215M.
Based on TIFF Advisory Services's 13F filing for Q2 2018, filed 10 Aug 2018.